Navigation Links
BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity
Date:9/27/2011

BILLERICA, Mass., Sept. 27, 2011 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the availability of the new BD Falcon™ Multi-Flask, a multi-layer cell culture device that will allow researchers to scale-up their cell culture easily and more efficiently.

Currently, most expansion of attachment-dependent cells occurs in single-layer flasks. The new BD Falcon Multi-Flask, available in both three- and five-layer designs (525 and 875 cm squared), simplifies cell culture scale-up by providing the same footprint, reagent volumes, and cell seeding densities per unit area as single-layer flasks but with three to five times more cell growth. The BD Falcon Multi-Flask also has the same proven tissue culture surface treatment as all other BD Falcon Flasks.

"The BD Falcon Multi-Flask will address the needs of researchers to grow more cells faster and more efficiently without compromising the quality of the cell culture," said Ken Linehan, Product Manager, BD Biosciences – Discovery Labware. "The BD Falcon Multi-Flask's pipet access and in-vessel mixing provide the convenience of a standard flask with the increased capacity of a multi-layer flask."

In addition to simplifying scale-up, the BD Falcon Multi-Flask features a mixing port that allows cells and media to be mixed inside the flask. This mixing process eliminates multiple steps from the cell culture workflow and reduces the risk of contamination.  Cells and media can be aspirated within the vessel using a pipet, which also eliminates steps and reduces contamination risks.

The BD Falcon Multi-Flask provides for a uniform distribution of media and cells to facilitate homogeneous cell growth on all layers. This uniform distribution of cells, combined with effective gas exchange and the Multi-Flask's proven vacuum gas tissue culture surface treatment, provides high cell yields and an ideal cell culture environment.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:
Jamie Yacco
Public Relations
(201) 847-4796
Jamie_Yacco@bd.com


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
2. Sangamo BioSciences Announces Presentation at the Sixth Annual JMP Securities Healthcare Conference
3. Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
4. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
5. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
6. Coronado Biosciences to Present at the Rodman & Renshaw Annual Global Investment Conference
7. Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference
8. Alzheimers Drug Discovery Foundation Supports Madera Biosciences with a Grant to Advance Novel Drug Candidates for Alzheimers Disease
9. Ardea Biosciences to Present at Wedbush Securities Life Sciences Conference
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
11. Magellan Biosciences Sells TREK Microbiology Business to Thermo Fisher Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
Breaking Medicine News(10 mins):